Osmolarity-Induced Altered Intracellular Molecular Crowding Drives Osteoarthritis Pathology
Kannan Govindaraj1, Marieke Meteling1, Jeroen van Rooij2
1Department of Developmental Bioengineering, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, Enschede, 7522NB, The Netherlands.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|January 12, 2024
Summary
Altered joint fluid osmolarity impacts chondrocyte behavior in osteoarthritis (OA). Lowering intracellular molecular crowding worsens OA, but higher extracellular osmolarity can reverse these detrimental effects.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Osteoarthritis (OA) is a complex joint disease with incompletely understood molecular mechanisms.
- Known factors like inflammation and matrix degradation are consequences, not initiators, of OA.
- The etiology of OA involves unknown contributing factors beyond current understanding.
Purpose of the Study:
- To investigate the role of microenvironmental osmolarity in OA pathophysiology.
- To identify novel mechanisms underlying chondrocyte behavior in OA.
- To explore osmolarity-based interventions for OA.
Main Methods:
- Analysis of intracellular molecular crowding in chondrocytes.
- Assessment of chondrocyte responses to inflammatory and anabolic stimuli under varying osmolarity conditions.
- Investigation of osmolarity-induced changes in chondrocyte metabolism.
Main Results:
- Microenvironmental osmolarity directly influences chondrocyte behavior, inducing and reversing OA-related characteristics.
- Decreased intracellular molecular crowding correlates with heightened sensitivity to pro-inflammatory triggers and reduced anabolic responsiveness.
- Exposure to higher extracellular osmolarity, mimicking healthy joints, renormalized chondrocyte sensitivity to catabolic stimuli and glycolytic metabolism.
Conclusions:
- Intracellular molecular crowding, modulated by microenvironmental osmolarity, represents a novel mechanism in OA pathophysiology.
- Osmolarity represents a potential therapeutic target for managing OA.
- Restoring normal joint osmolarity may reverse OA-associated chondrocyte dysfunction.
Related Concept Videos
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K


